DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

Search

Cross Country Healthcare Inc

Slēgts

SektorsRūpniecība

10.06 1.62

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.63

Max

10.08

Galvenie mērījumi

By Trading Economics

Ienākumi

-78M

-83M

Pārdošana

-13M

237M

Peļņas marža

-35.026

Darbinieki

7,890

EBITDA

12M

11M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+30.52% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 7. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

33M

322M

Iepriekšējā atvēršanas cena

8.44

Iepriekšējā slēgšanas cena

10.06

Ziņu noskaņojums

By Acuity

11%

89%

20 / 404 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

Cross Country Healthcare Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. apr. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Group Rejects EQT's Revised Offer

2026. g. 24. apr. 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Scoring the Cook Era -- Barrons.com

2026. g. 24. apr. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 24. apr. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:09 UTC

Peļņas

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

2026. g. 24. apr. 19:48 UTC

Tirgus saruna
Galvenie ziņu notikumi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

2026. g. 24. apr. 19:22 UTC

Peļņas

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

2026. g. 24. apr. 19:06 UTC

Peļņas

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

2026. g. 24. apr. 19:05 UTC

Tirgus saruna

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

2026. g. 24. apr. 18:30 UTC

Iegādes, apvienošanās, pārņemšana

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

2026. g. 24. apr. 18:28 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Rejects Revised EQT Offer

2026. g. 24. apr. 18:12 UTC

Tirgus saruna

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

2026. g. 24. apr. 18:06 UTC

Tirgus saruna

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

2026. g. 24. apr. 17:42 UTC

Peļņas

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Peļņas

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Tirgus saruna

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

2026. g. 24. apr. 17:12 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 24. apr. 17:11 UTC

Tirgus saruna

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

2026. g. 24. apr. 17:09 UTC

Tirgus saruna
Peļņas

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

2026. g. 24. apr. 17:09 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 17:06 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

2026. g. 24. apr. 16:51 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 24. apr. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Cross Country Healthcare Inc Prognoze

Cenas mērķis

By TipRanks

30.52% augšup

Prognoze 12 mēnešiem

Vidējais 13 USD  30.52%

Augstākais 15 USD

Zemākais 10 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Cross Country Healthcare Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

2

Pirkt

4

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

13.52 / 13.92Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

20 / 404 Rangs Rūpniecība

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Cross Country Healthcare Inc

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
help-icon Live chat